Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Red Light Holland Corp. C.TRIP

Alternate Symbol(s):  TRUFF

Red Light Holland Corp. is a Canada-based company. The Company is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal recreational market within the Netherlands. Its subsidiaries include RLH Netherlands BV, RLH Farms BV, Red Light Holland (Subco 1) Inc., SR... see more

CSE:TRIP - Post Discussion

Red Light Holland Corp. > 8 capital gives TRIP a buy rating with $.35 price target
View:
Post by SamRothstein on Oct 19, 2021 7:52pm

8 capital gives TRIP a buy rating with $.35 price target

Red Light Holland (link for entire article at bottom)

Current price: $0.23
Target price: $0.35

Red Light Holland’s aggressive acquisition strategy and foothold in the European recreational psilocybin retail market give it a competitive advantage.

“The Company’s Netherlands operations give it access to other low-barrier jurisdictions in Europe (e.g. Portugal, Czech Republic, etc). It has also established access to its iMicrodose kits for patients in Brazil, on a prescribed basis. Furthermore, RLH recently acquired Mera Life Sciences, a Caribbean-based operator where local regulations allow for the Company to work with naturally-derived psychedelic compounds including psilocybin, ibogaine, mescaline, dimethyltryptamine, and many others. RLH’s revenue-generating operations centered around production, sale, and distribution of psychedelic substances, stand to benefit from such broad access to psychedelic compounds as it works to expand its offerings, and its reach across more jurisdictions.”

https://www.benzinga.com/markets/cannabis/21/10/23016304/6-psychedelic-stocks-with-buy-rating-why-are-they-good-investments

Comment by swim on Oct 20, 2021 7:39pm
Positive, I'd like to see us moving upwards before years and heading into 2022.
Comment by Viguys on Oct 21, 2021 1:35pm
For sure,  my guess is mid to upper 40's by end of year.  Low $1.00 by February
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities